BCLC Stage C Hepatocellular Carcinoma

specific

End-stage hepatocellular carcinoma. Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41)

13

Centers

8

Active Trials

—

Cancer Funding

Top Centers for BCLC Stage C Hepatocellular Carcinoma(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
62.5
2
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
62.5
3
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
62.5
4
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
62.5
5
Boston University Cancer CenterBoston, MA
Active Research Program
62.5
6
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
62.5
7
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
62.5
8
The University of Vermont Cancer CenterBurlington, VT
Active Research Program
62.5
9
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
40.0
10
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
40.0
11
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
40.0
12
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
40.0
13
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
40.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →